These observations were substantiated by a series of both in vitro and in vivo studies that investigated the killing mediated by CTLs against a series of murine and human tumor cell lines wherein PI9 expression was associated with resistance to CTL killing and was consequently described as an immune escape mechanism [37, 41]. This evidence concerns the gene SERPINB9 and neoplasm.